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Objective: To describe the early results of penetrating
keratoplasty (PKP) in patients who had previously un-
dergone cultivated limbal epithelium transplantation.
Methods: Medical records of patients with limbal stem
cell deficiency due to chemical burnswhounderwent PKP
after cultivated limbal epithelium transplantation were
reviewed for demographics, primary etiology, type of lim-
bal transplantation, ocular surface stability, visual acu-
ity, graft clarity, and complications. Histopathologic fea-
tures of the recipient corneal buttons were studied with
special attention to epithelial status.
Results: Of the 125 patients with limbal stem cell defi-
ciency treated with cultivated limbal epithelium trans-
plantation, 15 underwent PKP at a mean interval of 7
months (range, 2-12 months) following cultivated lim-
bal epithelium transplantation (autologous, n=11; allo-
genic, n=4). All 4 patients treated with allogenic culti-
vated limbal epithelium transplantationwere undergoing
immunosuppressive therapy. Fourteen (93%) of the 15
eyes had a successful corneal graft with a stable corneal
epithelium. Preoperative best-corrected visual acuity was
less than 20/200 in 14 of the 15 eyes. At a mean±SD fol-
low-up of 8.3±5.0 months after PKP, the best-corrected
visual acuity was more than 20/60 in 8 eyes, 20/200 to
20/60 in 5 eyes, and less than 20/200 in 2 eyes. Three of
the 15 eyes experienced corneal allograft rejection, which
was managed successfully. One eye with graft rejection
also had glaucoma. None of the limbal epithelial allo-
grafts showed signs of rejection.
Conclusions: Early results of PKP following cultivated
limbal epithelium transplantation are favorablewhen per-
formed after stabilizing the ocular surface. Adequate im-
munosuppression is essential for allogenic cultivated lim-
bal epithelium transplantation to avoid rejection. Corneal
allografts can separately reject the limbal allografts.
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S EVEREOCULAR SURFACEDISOR-ders with limbal stem cell de-ficiency (LSCD) require acomplex approach of mul-tiple surgical procedures, such
as limbal transplantation and penetrating
keratoplasty (PKP), for final visual reha-
bilitation.1,2 The outcome of PKP in these
cases is reportedly poor.3,4 Penetratingkera-
toplastyperformed inaneyewithLSCDcar-
ries a high risk of rejection4-6 and non–
rejection-related failures. Use of systemic
cyclosporine to prevent rejection in these
high-risk grafts has beendiscussed at length
bymany authors,5,6 but considering the sig-
nificant adverse effects6,7 and high cost in-
volved with only a marginal improvement
in the outcome,6,8 the role of systemic cy-
closporine in these high-risk grafts is de-
batable. The poor results due to non–
rejection-related failure, such as persistent
epithelial defect, could be attributed to the
transferof only the transient amplifyingcells
onto the central corneal surface after PKP.
The transient amplifying cells, which have
a limited life span and limited proliferative
potential,9 fail to provide a stable epithelial
surface to thesegrafts,necessitating thecom-
binationwith a limbal transplantation pro-
cedure for better results. However, results
of various limbal transplantation proce-
dures combined with PKP are also not en-
couraging.10-12 Severelyaffectedpatientswith
unilateral LSCD require a large area of the
limbus fromcontralateral normal eyes, and
bilateral cases require similar tissues from
the donor. Both of these procedures carry
a risk of LSCD at the donor site.13 To avoid
this potential complication, cultivated lim-
bal epithelium transplantation is a better
choice in these cases.14 Because cultivated
limbal epithelium transplantation is a rela-
tively new technique, there are no reports
of the outcome of PKP following this pro-
cedure. We report herein the early results
of PKP after cultivated limbal epithelium
transplantation.
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METHODS
PATIENTS
During the study period (May 2001 to September 2002), 125
cultivated limbal epithelium transplantation procedures were
performed at L V Prasad Eye Institute, Hyderabad, India, on
eyes with a diagnosis of LSCD, of which 15 eyes of 15 patients
underwent PKP after the cultivated limbal epithelium trans-
plantation. Themedical records of patients who underwent PKP
after cultivated limbal epithelium transplantation were re-
viewed for demographics, primary etiology, previous surgical
procedures, preoperative and postoperative best-corrected vi-
sual acuity, type of cultivated limbal epithelium transplanta-
tion, complications, and final outcome. Histopathologic re-
ports of recipient corneal buttons were also reviewed. Clinical
photographs of the patients were studied with special atten-
tion to any abnormalities in the limbal region, vascular en-
gorgement, conjunctival staining, epithelial defect in the lim-
bal area, and conjunctivalization after the rejection episodes.
SURGICAL TECHNIQUES
Our surgical techniques for cultivated limbal epithelium trans-
plantation have previously been reported.15 In brief, following
approval from the Institute Ethics Committee, prior informed
consent was obtained from the patients or guardians. Limbal
biopsy was performed on the healthy contralateral eye or a
healthy area of the same eye in cases of autologous transplan-
tation and from the donor eye in cases of allogenic transplan-
tation. The procedure included careful dissection of a 33-mm
piece of conjunctival epithelium with 1 mm into clear corneal
stromal tissue at the limbus. The conjunctiva was excised just
behind the pigmented line (palisades of Vogt), and the limbal
tissue that contained epithelial cells and a part of the corneal
stroma was excised. Both tissues were transported in human
corneal epithelium medium to the tissue culture laboratory,
where under strict aseptic conditions the donor limbal tissue
was shredded into small pieces. These were implanted over the
central 10 mm of a 34-cm, deepithelialized, and preserved
human amniotic membrane. The cells were cultured using hu-
man corneal epithelial cell medium with 10% fetal bovine se-
rum. The growth was monitored daily, and the medium was
changed every 2 days. The culture was maintained for 10 to 15
days, by which time a confluent monolayer of the presumed
limbal epithelial cells around the implanted tissueswas achieved.
In the cases of LSCD with severe ocular surface dysfunction
that involved the conjunctival surface, a co-culture of limbal
and conjunctival epithelial cells was performed as previously
reported by Sangwan et al.15
At the time of limbal transplantation, the fibrovascular pan-
nus that covered the ocular surface was excised from the cor-
nea and sent for histopathologic examination. After release of
the symblepharon and adequate hemostasis with cautery, the
human amniotic membrane with the monolayer of cultivated
limbal epithelial cells was transplanted into the recipient. A ban-
dage contact lens was applied to prevent any damage from eye-
lid action. All of the cases were evaluated after the limbal trans-
plantation for corneal stromal scarring, and the cases with
scarring in the visual axis, leading to a decrease in vision, were
considered for PKP.
Penetrating keratoplasty was performed after a mean fol-
low-up of 7 months (range, 2-12 months) after cultivated lim-
bal epithelium transplantation, using donor corneas stored in
McCarey-Kaufmann medium. The recipient cornea was ex-
cised using a disposable handheld trephine,with 0.5mmof graft-
host disparity. The graft was secured by 10-0 nylon inter-
rupted sutures (extra sutureswere placed if necessary)withknots
buried on the donor side. The recipient corneal buttonwas sent
for histopathologic examination, and special attentionwas paid
to the epithelial status, epithelial stratification, and residual hu-
man amnioticmembrane. Lensectomy, anterior vitrectomy, and
intraocular lens insertion were performed, depending on the
clinical situation in each case. At the end of the surgery, a sub-
conjunctival injection of dexamethasone sodium phosphate
(4 mg/mL) and gentamicin sulfate (20 mg/mL) was given.
However, PKP in these conditions warrants special men-
tion of the difficulties encountered during the surgery. Be-
cause most of the cases followed chemical burns, resulting in
some collagenolysis, and had involved pannus resection with
or without superficial keratectomy, a significant disparity ex-
isted in graft-host thickness, leading to difficulty in graft host
apposition. Many of the patients had a disorganized anterior
segment with a complicated cataract, requiring lensectomy and
vitrectomy.
IMMUNOSUPPRESSION
Systemic immunosuppressants were administered to all pa-
tients with allogenic limbal grafts after adequate counseling re-
garding the adverse reactions. Baseline hematologic investiga-
tions and hepatic and renal parameters were obtained, and these
parameters were reassessed every 4 to 6weeks. Our routine im-
munosuppression protocol is to start cyclosporine therapy sys-
temically in a dosage of 5 to 7 mg/kg 48 hours before surgery,
along with methylprednisolone, 1 g intravenously, for the first
3 consecutive postoperative days. During the postoperative pe-
riod, cyclosporine was tapered to the maintenance dosage of
1.5 to 2 mg/kg over 4 to 8 weeks, with diltiazem hydrochlo-
ride, 90 mg, added as an adjunct to cyclosporine to reduce the
cost and increase serum levels of cyclosporine.16,17 Diltiazem
also decreases the dose required to achieve immunosuppres-
sion and thus decreases the cost of the treatment. Diltiazem by
its antihypertensive effect helps to control hypertension, which
is the most common systemic adverse effect of the cyclospor-
ine.17 Use of immunosuppressants is being continued in all of
these patients. Both patients with allogenic-cultivated limbal
epithelium transplantation received systemic prednisolone ac-
etate, 1mg/kg, whichwas tapered on aweekly basis to themain-
tenance dosage of 5 mg/d.
When rejection developed, patients were treated with fre-
quent topical corticosteroids. Patientswhounderwent allogenic-
cultivated limbal epitheliumtransplantation received systemic cor-
ticosteroids with continuing systemic immunosuppressants.
PATIENT FOLLOW-UP
Following cultivated limbal epithelium transplantation, all pa-
tients were treated with 1% prednisolone acetate eye drops 8
times a day tapered to once a day in 5 to 6weeks and 0.3% cipro-
floxacin hydrochloride eye drops 4 times a day for 1 week. Use
of the 0.3% ciprofloxacin eye drops was continued if there were
any epithelial defects or until the bandage contact lenswas used.
We used to apply a bandage contact lens postoperatively, but
we have recently stopped this because we believe that it is not
required. The patients who underwent allogenic-cultivated lim-
bal epithelium transplantation were treated with 1% predniso-
lone eye drops 2 times hourly, which was tapered to once a day
at 6 months, and these patients also received immunosuppres-
sants as described herein. The patients were seen on postop-
erative day 1, week 1, week 2, week 5, and monthly thereafter.
Each examination included a complete history, notation of new
ocular or systemic symptoms, a complete evaluation of the re-
cipient and donor sites, and notation of any signs of neovas-
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cularization or surface instability. Patients were prescribed 0.3%
ciprofloxacin hydrochloride eye drops 4 times a day for 1 week
or until the epithelial defect healed. All of the patients who un-
derwent allogenic-cultivated limbal epithelium transplanta-
tion continued with adequate immunosuppression. Follow-
ing PKP, all patients were seen on day 1, day 2, week 1, week
2, week 5, monthly for 6 months, 3 times monthly for 1 year,
and 6 timesmonthly after that. At each visit, patients were asked
about any new symptoms suggestive of corneal graft rejection
and underwent a thorough examination, including assess-
ment of visual acuity and ocular surface stability. All patients
were educated about the symptoms of rejection at each visit.
Any event of rejection was treated with an hourly instillation
of 1% prednisolone acetate eye drops tapered to the previous
dosage in a month’s time and a single dose of 1 g of intrave-
nous methylprednisolone.
OUTCOME MEASURES
Primary graft failure was defined by nonresolving graft edema
at 2 weeks. Graft rejection was diagnosed by slitlamp biomi-
croscopy findings and was subdivided into epithelial, subepi-
thelial, and endothelial rejection. Failure of PKP was defined
as nonresolving graft edema 3months after graft rejection, per-
sistent epithelial defect, or conjunctivalization.
RESULTS
CLINICAL RESULTS
A total of 15 eyes of 15 patients underwent cultivated lim-
bal epithelium transplantation followed by PKP for LSCD
with a mean±SD follow-up of 15.3±5.1 months after cul-
tivated limbal epithelium transplantation and 8.3±5.0
months after PKP. All 15 eyes underwent PKP 2 to 12
months (mean, 7 months) after cultivated limbal epithe-
lium transplantation. The patients ranged in age from 3 to
36 years (mean±SD, 20.3±9.9 years), and 11 were male
and 4 female. In all 15 eyes the origin of LSCDwas chemi-
cal burns, ofwhich 11were alkali burns, 3were acid burns,
and1wasdue to anunknownchemical (Table). Six (40%)
of the 15 eyes had a history of surgery in the form of allo-
genic bone marrow transplantation in 3 eyes (20%), PKP
in 2 eyes (13%), and limbal transplantation in 1 eye (7%).
Eight (53%) of the 15 eyes had symblephara, ranging
from the 2- to 10-o’clock hours. Fourteen (93%) of the
15 eyes had total LSCD with 360° loss of limbal pali-
sades of Vogt and 360° conjunctivalization, whereas 1
(7%) of 15 had partial LSCD with loss of limbal pali-
sades of Vogt of 120° and pannus localized to that area
(Table).
Eleven of the 15 eyes were autografts, of which 9were
from the contralateral normal eyes and 2 were from the
unaffected area of the same eye. Three of the 15 were liv-
ing related allografts, and 1 was a nonrelated allograft.
All of the eyes underwent cultivated limbal epithelium
transplantation except 3 eyes, in which a co-cultivated
(limbal and conjunctival) epithelium transplantationwas
performed (Table). All 4 patients with limbal allografts
underwent immunosuppression with cyclosporine and
systemic corticosteroids, and 2 of them received diltia-
zem tablets to decrease the dosage of cyclosporine.
The preoperative best-corrected visual acuity on the
Snellen chart was less than 20/200 in 14 (93%) of 15 eyes
Table. Patient Profiles
Age, y /
Sex Origin Type of CLT
Preoperative
BCVA
Final
BCVA
Post-CLT
Follow-up, mo
Post-PKP
Follow-up, mo
Duration of
CLT to PKP, mo
Post-PKP
Complications
3/F Alkali burns Contralateral-autologous* PL + PR 20/200 20 11 9 Amblyopia
11/F Alkali burns Contralateral-autologous* CF 20/40 12 5.5 6.5
26/M Alkali burns Living-related allogenic* CF 20/160 15.5 5.5 10 Corneal allograft
rejection, glaucoma
14/M Alkali burns Contralateral-autologous 20/100
partial
20/40 16 2 14
21/M Acid burns Contralateral-autologous† CF 20/40 19 13 6
36/M Acid burns Contralateral-autologous PL + PR CF 18 7 11 Primary corneal
graft failure
6/F Alkali burns Contralateral-autologous HM 20/30 17 13 4
20/M Alkali burns Contralateral-autologous CF 20/50partial 22 18.5 3.5
29/M Acid burns Ipsilateral-autologous CF 20/80 7 1.5 5.5
7/M Alkali burns Contralateral-autologous HM CF 24 12 12 Corneal allograft
rejection
23/F Unknown
chemical
Nonrelated allogenic PL + PR 20/50 8.5 3 5.5
29/M Alkali and
acid burns
Living related allogenic CF 20/125 7 4 3
25/M Alkali burns Contralateral-autologous CF 20/40 15 9.5 5.5
25/M Alkali burns Living related allogenic HM 20/50 15 13 2 Corneal graft rejection
(epithelium and
endothelium)
30/M Alkali burns Ipsilateral-autologous CF 20/80 13 6 7
Abbreviations: BCVA, best-corrected visual acuity; CF, counting fingers; CLT, cultivated limbal epithelium transplantation; HM, hand motions; PKP, penetrating
keratoplasty; PL, perception of light; PR, projection of rays.
*Co-cultivated (limbal and conjunctival) limbal epithelium.
†Combined with contralateral conjunctivolimbal autograft.
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and 20/200 or better in 1 (7%) of 15 eyes. Final best-
corrected visual acuity was less than 20/200 in 2 eyes
(1 of which had primary graft failure), 20/200 to 20/60
in 5 eyes, and better than 20/60 in 8 eyes (Figure 1 and
Figure 2). Thirteen corneal allografts (87%) were clear
at the last follow-up. Of the other 2, 1 was a primary fail-
ure and 1 had resolving corneal allograft rejection.
Three of 15 eyes had acute corneal allograft rejec-
tion, of which 2 had living related cultivated limbal epi-
thelium transplantation and 1 had autologous culti-
vated limbal epithelium transplantation. Two eyes had
only endothelial rejection, whereas 1 eye had combined
endothelial and epithelial rejection. One eye with graft
rejection also had glaucoma, which was controlled with
the treatment. All of the rejected corneal allografts re-
sponded favorably to the treatment.
HISTOPATHOLOGIC RESULTS OF RECIPIENT
CORNEAL BUTTONS
All corneal buttons showed amultiple-layered normal cor-
neal epithelium of 3 to 5 layers (Figure3D). Only 2 cor-
neal buttons showed the presence of residual amniotic
membrane. One of the corneal buttons showed a focal
presence of goblet cells. Immunohistochemical analysis
with monoclonal antibodies (AE5) against cornea-
specific cytokeratin K3 was performed on 12 recipient
corneal buttons, of which 11 showed reactions positive
for the cornea-specific phenotype of the epithelium
(Figure 4F).
COMMENT
The limbal stem cell can be damaged by a variety of in-
sults, of which one of the most common and important
is chemical burns.9 Most of these cases of chemical burns
have significant stromal scarring, necessitating PKP for
visual rehabilitation. Before the role of limbal stem cells
as a source of corneal epithelium was recognized, PKP
in these eyes invariably failed.3 This was because the tran-
sient amplifying cells that were transferred onto the cen-
tral corneal surface during PKP had a limited life span
and limited proliferative potential9 and thus were un-
able to restore the ocular surface epithelium on a long-
term basis. Limbal transplantation is performed in these
cases to maintain the reservoir of corneal epithelial cells
required for a stable and healthy corneal epithelium. Si-
multaneous PKP and limbal transplantation and their ad-
vantages have been addressed previously,18,19 but a greater
risk of rejection of corneal grafts exists10,20 with an in-
flamed and vascularized recipient corneal stroma.4-6,21
Therefore, we prefer the 2-staged approach. The first stage
is ocular surface reconstruction by cultivated limbal epi-
thelium transplantation followed by the second stage of
visual rehabilitation by performing PKP.
Various techniques of limbal transplantation have been
reported in the literature, including keratolimbal allo-
graft, which has produced disappointing long-term out-
comes.10,12 The need for indefinite immunosuppression is
also an issue in cases of allogenic limbal transplantation.
The other techniques, such as living related conjunctival
limbal allogenic transplantation andconjunctival limbal au-
tografts,maynot be useful in total LSCD to replace the lim-
bus in 360° owing to the risk of LSCD at the donor site.13
Hence, we prefer the technique of cultivated limbal epi-
thelium transplantation. However, our technique of culti-
vated limbal epithelium transplantation is different from
that reported by others.14,22 As reported previously,15 we
used deepithelialized human amniotic membrane to cul-
tivate limbal epithelium over it without 3T3 fibroblast co-
culture or air lifting.Our culture durationwas also shorter
becausewe did not wait formultiple layers to form. In our
experience, a monolayer ultimately proliferates in vivo to
producestratified (multilayered)epitheliumfollowing trans-
plantation.Our hypothesis is supported by the fact that fol-
lowing PKP, all of the recipient corneal buttons showed
normal stratified corneal epithelium(Figure3D)with a cor-
nea-specific phenotype (Figure 4F),which had grown into
multiple layers aftermonolayer transplantation (Sangwan
et al, unpublished data, 2001).
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Figure 1. Change in best-corrected visual acuity (BCVA) of the studied eye
from prelimbal transplantation to the last follow-up after penetrating
keratoplasty.
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Figure 2. Comparison of preoperative and postoperative visual acuity at the
last follow-up. CF indicates counting fingers; PL, perception of light.
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Cases of severe ocular surface damage with LSCD are
often difficult tomanage. Apart from limbal damage, con-
junctival deficiency usually occurs as well. We tried to
address this problem earlier and reported co-cultivation
of conjunctival and limbal epithelial cells.15 Three of the
15 patients in this series had more severe ocular surface
damage with symblephara and hence underwent co-
cultivated (limbal and conjunctival) epithelium trans-
plantation.
All of the recipients in our study were younger, rang-
ing in age from 3 to 36 years (mean age, 20.3 years)
(Table), sustained chemical burns, and subsequently had
stromal vascularization in 4 quadrants. Eleven of the 15
patients in our study had a history of ocular surface sur-
gical procedures, and 8 of the patients had symblephara
at initial examination.Hence, considering the criteria sug-
gested by theCollaborativeCorneal Transplantation Stud-
ies Research Group4 for high-risk PKPs, all PKPs in our
series were high risk. Conversely, our cases showed nei-
ther a high rejection rate (overall rejection rate, 20%) de-
spite the age of the recipients and stromal vasculariza-
tion nor a non–rejection-related failure as expected in
cases of chemical burns.4 This substantial decrease of non–
rejection-related failure could be explained by the cul-
tivated limbal epithelium transplantation procedure pre-
ceding the PKP, which continued to supply healthy
epithelium after PKP. Similarly, the fewer corneal graft
rejection episodes, notwithstanding age of recipients and
vascularized recipient corneal stroma, could be due to
our stepwise approach, which included ocular surface re-
construction by cultivated limbal epithelium transplan-
tation in the first step and PKP in the second. Because 4
of the 15 patients underwent allogenic limbal epithe-
lium transplantation and immunosuppression, the effect
of immunosuppression on the graft survival also cannot
be overlooked. However, if we consider only the autolo-
gous limbal epithelium transplantation cases, all of them
met the criteria of high-risk grafts and none were immu-
nosuppressed. The corneal graft rejection rate in these
cases was 9.1% (1 of 11), which is less than in any other
reported series of high-risk grafts without immunosup-
pression, as described by Hill5 (73%), Poon et al6 (53%),
and Rumelt et al (42%).21 To explain this relatively low
rejection rate, we speculate that the cultivated limbal epi-
thelium is devoid of Langerhans cells,23 which are be-
lieved to be the antigen-presenting cells and are in abun-
dance at the limbus, forming one of the important
components of the afferent arm of corneal allograft re-
jection.24 Thus, the recognition of corneal graft alloan-
tigen is down-regulated, which in turn decreases the rate
of rejection. However, further studies are needed in this
direction to confirm our hypothesis. Similarly, we can-
A B
C D
Figure 3. Slitlamp photographs of case 5. A, Preoperative condition showing total limbal stem cell deficiency with extensive symblephara obliterating the superior
and inferior fornices. B, Stable ocular surface and dense corneal scarring after autologous cultivated limbal epithelium transplantation with contralateral
conjunctivolimbal autograft (6 weeks postoperatively). Bulbar conjunctiva, in the area of conjunctivolimbal autograft (inferior quadrant), shows a patch of
vascularization and pigmentation. C, Clear and compact graft with a stable ocular surface after penetrating keratoplasty (13 months postoperatively).
D, Hematoxylin-eosin–stained histopathologic section of the corneal button with multilayered corneal epithelium after autologous cultivated limbal epithelium
transplantation (original magnification  20).
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not rule out the effect of the anti-inflammatory property
of amniotic membrane,25 which was used as a carrier in
these cases. We also noted that despite the central cor-
neal graft rejection in 2 cases of allogenic limbal epithe-
lium transplantation, none showed any signs of limbal
allograft rejection. This finding supports similar find-
ings with PKP after keratolimbal allograft transplanta-
tion reported by Shimazaki et al.26
Several studies18,27,28 have indicated that all allogenic
limbal transplantation cases, including those with living-
related limbal allografts, require immunosuppression.We
too believe in immunosuppression for allogenic culti-
vated limbal transplantation. Hence, we started admin-
istration of cyclosporine preoperatively and then con-
tinued with a maintenance dosage of cyclosporine for
indefinite periods in the recipients with allogenic culti-
vated limbal epithelium transplantation. Along with sys-
temic cyclosporine, we used diltiazem, a calcium chan-
nel blocker. Diltiazem is known to increase the plasma
cyclosporine level by competitive inhibition of hepatic
enzyme CYP450, which is required for the metabolism
of cyclosporine. Thus, the cyclosporine dose can be re-
duced by 30% to 50% with a drastic reduction in medi-
cation cost.16 In high nontherapeutic doses, however, it
may exert an immunosuppressive effect.17 It also pro-
vides renal protection from cyclosporine-induced neph-
rotoxicity.29 It is used in other solid organ transplanta-
tions but has not been reported for allogenic limbal
transplantation.
Previous studies10-12,22 reported a poor final visual out-
come of PKP with limbal transplantation. In our study,
14 (93%) of the 15 patients had a preoperative best-
corrected visual acuity of handmovements to finger count-
ing. At the last follow-up, 13 patients (87%) had an am-
bulatory visual acuity of better than 20/200 in the affected
eye, of which 8 (53%) achieved a best-corrected visual
acuity better than 20/60 (Figure 3). Although ours was
a retrospective study, with a small number of cases and
long-term results that are still awaited, we observed a defi-
nite trend toward better corneal graft survival and ex-
cellent visual outcome in these cases.
Certain issues related to PKP following limbal trans-
plantationmust behighlighted. Because suchpatients have
already undergone pannus resection with or without su-
perficial keratectomy, the recipient corneal stromal bed
is usually thin and irregular, which could result in post-
operative astigmatism. Associated conditions, such as eye-
lid abnormalities, glaucoma, and dry eye syndrome, may
affect the final outcome and hence must be treated be-
fore PKP. Patients treated with allogenic limbal epithe-
lium transplantation need to undergo immunosuppres-
sion even after the PKP.
In summary, we report the early outcome in 15 cases
of PKP after cultivated limbal epithelium transplanta-
tion, which showed favorable results in the form of cor-
neal graft survival and final visual acuity. However, fur-
ther studies are required to understand immunologic
rejection in cases of allogenic cultivated limbal epithe-
lium transplantation.
Submitted for Publication: December 5, 2003; final re-
vision received May 24, 2004; accepted July 12, 2004.
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Figure 4. Slitlamp photograph of case 14. A, Preoperative condition showing total limbal stem cell deficiency and dense corneal scarring. Note extensive
conjunctivalization of the cornea. B, Relatively quiet eye showing stable ocualr surface with deep vessels in 2 quadrants and dense corneal scarring in the visual
axis after living-related cultivated limbal epithelium transplantation (7 weeks postoperatively). C, Clear and compact graft with stable ocular surface after
penetrating keratoplasty (4 months postoperatively). D, Combined epithelial and endothelial rejection (7.5 months after penetrating keratoplasty). Note stromal
edema in the inferior half of the graft and epithelial rejection line (black and white arrowheads). E, Clear graft (13 months after penetrating keratoplasy) after
successful treatment of corneal allograft rejection. F, Photomicrograph of a section of the corneal button showing positive staining for cytokeratin K3 on
immunolabeling with specific monoclonal antibody AE5 suggestive of a cornea-specific type of differentiation (original magnification  40).
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Correction
Notice of Duplicate Publication of Figure. In the Clini-
cal Sciences article by Sangwan et al titled “Early Re-
sults of Penetrating Keratoplasty After Cultivated
Limbal Epithelium Transplantation,” published in the
March 2005 issue of the ARCHIVES (2005;123:334-340),
Figure 3 is the same figure as one previously published
in an article by Sangwan et al (Figure 2) that appeared
in Bioscience Reports (2003;23:169-174). The authors
alerted us to the duplicate publication of the figure when
they realized the error. This was an unintentional over-
sight. The ARCHIVES has since obtained permission from
Springer Science and Business Media, the publisher of
Bioscience Reports, to reprint the figure.
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